Hamps Bio Peer Comparison
BSE: 544312
₹22.95
₹-2.55
(-10.00%)
As on 17-Sep-2026IST
Market cap
₹20 Cr
Revenue (TTM)
₹8 Cr
P/E Ratio
--
P/B Ratio
2.5
Div. Yield
0 %
Edit
| Hamps Bio | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
20 | 48,875 | 7,923 | 1,087 | 60 |
Revenue (₹ Cr) |
8 | 6,725 | 7,229 | 287 | 21 |
Net Profit (₹ Cr) |
-0.74 | 1,128.79 | 210.43 | 28.67 | 3.24 |
Net Margin (%) |
-8.39 | 16.02 | 2.88 | 9.68 | 15.18 |
RoE (%) |
-8.74 | 11.51 | 11.02 | 9.14 | 19.12 |
Price to Earnings |
-- | 43.30 | 37.65 | 35.19 | 18.47 |
Price-To-Book |
2.47 | 4.60 | 3.96 | 4.30 | 3.22 |
Income Statement (₹ Cr)
| Hamps Bio | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
|
Operating Revenue
|
8.47 | 6,430.65 | 6,892.47 | -- | -- |
|
Total Income
|
8.81 | 6,746.98 | 6,963.79 | -- | -- |
|
Total Expenditure
|
8.44 | 4,801.11 | 6,268.09 | -- | -- |
|
EBITDA
|
0.04 | 1,629.54 | 624.38 | -- | -- |
|
Depreciation
|
0.82 | 423.67 | 282.87 | -- | -- |
|
EBIT
|
-0.78 | 1,205.88 | 341.51 | -- | -- |
|
Interest
|
0.25 | 33.28 | 137.50 | -- | -- |
|
Other Income
|
0.33 | 316.33 | 71.32 | -- | -- |
|
Exceptional Items
|
-- | -24.35 | -- | -- | -- |
|
Profit before Tax
|
-0.70 | 1,464.58 | 275.33 | -- | -- |
|
Provision for Tax
|
0.04 | 437.26 | 55.72 | -- | -- |
|
Profit after Tax
|
-0.74 | 1,027.32 | 219.61 | -- | -- |
Liabilities (₹ Cr)
| Hamps Bio | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
8.10 | 10,357.95 | 1,975.36 | -- | -- |
|
Minority Interest
|
-- | -- | -0.71 | -- | -- |
|
Non-Current Liabilities
|
4.15 | 482.17 | 1,225.00 | -- | -- |
|
Current Liabilities
|
3.62 | 1,608.40 | 763.90 | -- | -- |
|
Total Liabilities
|
15.92 | 12,448.52 | 4,084.80 | -- | -- |
Assets (₹ Cr)
| Hamps Bio | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
10.57 | 4,921.74 | 1,820.29 | -- | -- |
|
Current Assets
|
5.30 | 7,526.79 | 2,143.26 | -- | -- |
|
Total Assets
|
15.92 | 12,448.52 | 4,084.80 | -- | -- |
|
Total Debt*
|
6.88 | 243.36 | 0.00 | -- | -- |
|
Net Current Assets
|
1.68 | 5,918.38 | 1,379.36 | -- | -- |
|
Contingent Liabilities
|
-- | 10.12 | 14.06 | -- | -- |
Cashflow (₹ Cr)
| Hamps Bio | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-0.71 | 1,031.39 | 495.58 | -- | -- |
|
Cash Flow from Investing Activities
|
-2.93 | 137.73 | -127.72 | -- | -- |
|
Cash from Financing Activities
|
3.72 | -416.97 | -255.51 | -- | -- |
|
Net Cash Inflow / Outflow
|
0.07 | 752.14 | 112.36 | -- | -- |
Ratios
Profitability Ratios
| Hamps Bio | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-3.35 | 14.96 | 22.22 | -- | -- |
|
ROE (%)
|
-8.74 | 10.56 | 11.93 | -- | -- |
|
ROA (%)
|
-5.17 | 8.70 | 6.00 | -- | -- |
|
EBIT Margin (%)
|
4.36 | 30.26 | 10.09 | -- | -- |
|
Net Margin (%)
|
-8.39 | 15.23 | 3.15 | -- | -- |
|
Cash Profit Margin (%)
|
0.92 | 22.56 | 7.19 | -- | -- |
Growth Ratios
| Hamps Bio | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
27.08 | 14.50 | 12.33 | -- | -- |
|
EBIT Growth (%)
|
-59.89 | 31.25 | 26.01 | -- | -- |
|
Net Profit Growth (%)
|
-348.14 | 47.07 | 46.18 | -- | -- |
|
EPS Growth (%)
|
-348.14 | 47.07 | 45.68 | -- | -- |
|
Book Value Growth (%)
|
-7.95 | 12.70 | 14.76 | -- | -- |
Valuation Ratios
| Hamps Bio | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
|
Price / Earnings
|
0.00 | 27.22 | 45.79 | -- | -- |
|
Price / Book Value
|
1.78 | 2.71 | 5.11 | -- | -- |
|
Dividend Yield (%)
|
0.00 | 1.18 | 0.00 | -- | -- |
|
EV/EBITDA
|
57.24 | 12.77 | 13.79 | -- | -- |
|
Market Cap (₹ Cr)
|
14.42 | 27,964.97 | 10,057.49 | -- | -- |
Solvency Ratios
| Hamps Bio | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.85 | 0.02 | 0.00 | -- | -- |
|
Short term debt to equity ratio
|
0.09 | -- | -- | -- | -- |
|
Current Ratio
|
1.46 | 4.68 | 2.81 | -- | -- |
|
Quick Ratio
|
0.75 | 3.60 | 1.00 | -- | -- |
|
Interest Coverage
|
-1.77 | 45.01 | 3.00 | -- | -- |
Operating Efficiency Ratios
| Hamps Bio | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
18.71 | 29.41 | 0.39 | -- | -- |
|
Asset Turnover
|
0.59 | 0.54 | 1.91 | -- | -- |
|
Receivable days
|
59.81 | 96.72 | 1.05 | -- | -- |
|
Inventory Days
|
106.86 | 97.32 | 71.25 | -- | -- |
|
Payable days
|
57.11 | 134.60 | 21.75 | -- | -- |
|
Cash Conversion Cycle
|
109.56 | 59.43 | 50.55 | -- | -- |
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
